Reliable Dapagliflozin Solvate API Supply by Amber Lifesciences

Dapagliflozin Propanediol Solvate API is an important active pharmaceutical ingredient used in the treatment of Type 2 Diabetes Mellitus. It belongs to the SGLT2 inhibitor class and helps reduce blood glucose levels by increasing glucose excretion through urine. The growing prevalence of diabetes worldwide has significantly increased demand for this API. Pharmaceutical manufacturers are actively sourcing high-quality Dapagliflozin Propanediol Solvate API to develop effective diabetic formulations for domestic and international markets.

Dapagliflozin Propanediol Solvate API – Key Information

Product Name: Dapagliflozin Propanediol Solvate API
Generic Name: Dapagliflozin Propanediol Monohydrate (Solvate)
CAS Number: 960404-48-2
Molecular Formula: C₂₄H₃₅ClO₉
Molecular Weight: 502.98 g/mol

Pharmacological Class

  • SGLT2 Inhibitor – Inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting glucose excretion through urine.
  • Antidiabetic Agent – Used for the management of Type 2 Diabetes Mellitus and blood glucose control.
  • Cardiorenal Therapy API – Supports treatment strategies for cardiovascular and chronic kidney disease risk reduction in eligible patients.
  • Active Pharmaceutical Ingredient (API) – Widely used in the manufacturing of tablets and combination antidiabetic formulations.

North America Leads Global Market Demand

The North American market, particularly the United States, represents one of the largest demand centers for Dapagliflozin Propanediol Solvate API. High diabetes prevalence, advanced healthcare infrastructure, and increasing adoption of innovative antidiabetic therapies contribute to market growth. The region continues to invest heavily in diabetes management solutions, creating substantial opportunities for API suppliers. Europe and emerging Asian markets also show strong growth, but North America remains a key revenue-generating region.

Rising Applications Across Diabetes Treatment Segments

The API is primarily utilized in the production of oral antidiabetic medications for Type 2 diabetes management. Healthcare providers increasingly use dapagliflozin-based formulations due to their effectiveness in controlling blood sugar and supporting cardiovascular health. Additionally, ongoing clinical research has expanded its applications in heart failure and chronic kidney disease treatments. These broader therapeutic uses continue to drive demand among pharmaceutical companies seeking reliable API manufacturers.

Regulatory Compliance Ensures Global Market Access

Manufacturers supplying Dapagliflozin Propanediol Solvate API must comply with stringent international regulatory standards. Certifications such as WHO-GMP, USFDA, EU-GMP, and other country-specific approvals are essential for market entry. Regulatory authorities require comprehensive documentation covering manufacturing processes, quality control procedures, stability data, and safety evaluations. Compliance with these standards helps pharmaceutical companies ensure product quality, safety, and international acceptance.

Import Registration Process For Pharmaceutical Products

Importing Dapagliflozin Propanediol Solvate API generally requires regulatory registration in the destination country. Importers must submit Drug Master Files (DMFs), Certificates of Analysis (COAs), GMP certificates, and product specifications. Regulatory authorities review documentation before granting import approval. Countries may have additional requirements based on local pharmaceutical regulations. Working with an experienced API supplier helps streamline registration and reduce approval timelines.

Expanding Opportunities In Emerging Healthcare Markets

Rapid growth in diabetes cases across Asia-Pacific, Latin America, and the Middle East creates significant opportunities for API suppliers. Increasing healthcare awareness, government initiatives, and expanding pharmaceutical manufacturing capabilities are driving market expansion. Demand for affordable and effective diabetic medications continues to rise, encouraging pharmaceutical companies to establish partnerships with reliable API manufacturers. These trends support long-term growth prospects for Dapagliflozin Propanediol Solvate API.

Why Choose Amber Lifesciences Manufacturing Expertise

Amber Lifesciences offers high-quality Dapagliflozin Propanediol Solvate API manufactured under strict quality standards. The company focuses on regulatory compliance, consistent product quality, and reliable global supply capabilities. With advanced manufacturing infrastructure and comprehensive quality assurance systems, Amber Lifesciences supports pharmaceutical companies in developing effective diabetic formulations. Their commitment to customer satisfaction and international standards makes them a trusted API manufacturing partner.

Frequently Asked Questions About This API

Q1. What is Dapagliflozin Propanediol Solvate API used for?
It is used in manufacturing medicines for Type 2 diabetes, heart failure, and kidney disease management.

Q2. Which region has the highest demand?
The United States and broader North American market currently represent the highest demand region.

Q3. What certifications are important for suppliers?
WHO-GMP, USFDA, EU-GMP, and other international regulatory certifications are highly important.

Q4. Is registration required before import?
Yes, most countries require product registration and regulatory documentation before import approval.

Q5. Why is market demand increasing?
Growing diabetes prevalence and expanding therapeutic applications continue to drive global demand.